COVID-19 TESTING: THE PANDEMIC ISN’T DONE. NEITHER ARE WE.

COVID-19 TESTING:
THE PANDEMIC ISN'T DONE.
NEITHER ARE WE.

WITH VARIANTS PRESENT AND VACCINES ROLLING OUT, RELIABLE TESTING AND CARE REMAIN CRUCIAL. HERE'S WHAT TO KNOW.

COVID-19 DELTA VARIANT: WHAT YOU NEED TO KNOW

COVID-19 DELTA VARIANT:
WHAT YOU NEED TO KNOW

The pandemic's re-emergence in daily life can be worrying. Testing can help bring back peace of mind.

PENCILS, CHECK. NOTEBOOKS, CHECK. COVID TESTING, CHECK.

PENCILS, CHECK.
NOTEBOOKS, CHECK.
COVID TESTING, CHECK.

Rapid antigen testing with BinaxNOW can help keep kids healthy and schools and communities open this fall.

 

THIS FIGHT FOR THE WORLD'S HEALTH IS NOT OVER

When COVID-19 shut down the world's economy and activity, we got busy ramping up capabilities to offer the world the testing it needed to track infections and get people back to doing the things they love sooner. Even as humanity re-emerges to renewed normalcy, we continue working across our company and in partnership with others to offer resources and technologies to fight this still evolving threat, including variants such as Delta. And it's not limited to diagnostics. We continue to ensure access to medical devices, medicines and nutrition products.

 

 

ANTIGEN TESTING
FLU VS. COVID: HOW TO TELL THEM APART

FLU VS. COVID: HOW TO
TELL THEM APART

COVID isn't the flu. Here's what you need to know and how testing can help you know what you're treating.

Scaling Back Up To Make Rapid Tests Even More Available READ MORE
Scaling Back Up To Make Rapid Tests Even More Available
As we head into the winter months, we're continuing to deploy all of our resources to help meet skyrocketing test demand.
COVID-19 MU AND R.1 VARIANTS: WHAT YOU NEED TO KNOW READ MORE
COVID-19 MU AND R.1 VARIANTS: WHAT YOU NEED TO KNOW
Like Delta and other strains of COVID-19, our tests can detect these so you can make plans to feel better.
BINAXNOW: WHAT YOU NEED TO KNOW READ MORE
BINAXNOW: WHAT YOU NEED TO KNOW
A step-by-step video guide to conducting a BinaxNOW Self Test in the comfort of your own home.

BinaxNow Home Test

For the professional use and at-home versions of BinaxNOW, you can receive verified tests results to your phone via our NAVICA mobile app.

 

 

DOWNLOAD THE APP

Get the app before your first test.

 

Apple Store

Google Play

MOLECULAR TESTING
IDNOW: THE FOREFRONT OF COVID-19 TESTING

IDNOW: THE FOREFRONT
OF COVID-19 TESTING

Portable, reliable and rapid, with results on the spot, all in the
size of a toaster. Difference making innovation.

REDUCING RISK WITH RELIABLE POINT-OF-CARE TESTING READ MORE
REDUCING RISK WITH RELIABLE POINT-OF-CARE TESTING
ID NOW delivers results in minutes where they're needed most, helping to diagnose COVID-19.
ABBOTT LAUNCHES NOVEL CORONAVIRUS TEST READ MORE
ABBOTT LAUNCHES NOVEL CORONAVIRUS TEST
Test will be used on our m2000 RealTime system available in hospitals and molecular labs in the U.S.
COVID-19 MOLECULAR TEST ON NEW ALINITY M SYSTEM READ MORE
COVID-19 MOLECULAR TEST ON NEW ALINITY M SYSTEM
Alinity m is highly advanced and greatly improves speed and efficiency, running up to 1,080 tests in 24 hours.
HOW CORONAVIRUS MOLECULAR TESTING WORKS HOW CORONAVIRUS MOLECULAR TESTING WORKS HOW CORONAVIRUS MOLECULAR TESTING WORKS HOW CORONAVIRUS MOLECULAR TESTING WORKS
COVID COVID COVID COVID
COVID-19 COVID-19 COVID-19 COVID-19
COVID-19 COVID-19 COVID-19 COVID-19
COVID-19 COVID-19 COVID-19 COVID-19
ANTIBODY TESTING
ABBOTT'S COVID-19 ANTIBODY TEST

ABBOTT'S COVID-19 ANTIBODY TEST

Test can help determine if someone was infected with the virus and if the person has developed antibodies.

ANTIBODIES: HELPING YOU FIGHT COVID-19 READ MORE
ANTIBODIES: HELPING YOU FIGHT COVID-19
Antibodies are key to health. We're breaking down what they are, how your body makes them and why they matter.
HOW DOES COVID-19 ANTIBODY TESTING WORK? READ MORE
HOW DOES COVID-19 ANTIBODY TESTING WORK?
In less than 10 minutes you can have a COVID-19 antibody test with results following soon. Here's how it works.
WHAT'S TRUE, AND WHAT'S NOT, ABOUT ANTIBODY TESTING READ MORE
WHAT'S TRUE, AND WHAT'S NOT, ABOUT ANTIBODY TESTING
What you may have heard about COVID-19 antibody testing may not match reality.
MORE THAN TESTING
AR. VR. We Are ... There for You

AR. VR. We Are ... There for You

For training, proctoring and more, we're connecting with doctors for ongoing learning so they can be there for you.

WE WELCOME YOUR CARE EXPECTATIONS READ MORE
WE WELCOME YOUR CARE EXPECTATIONS
Remotely delivered care isn't going anywhere. We're connected in ways that are only going to get stronger.
NEW: DIGITAL PRESCRIPTION FOR PAIN & MOVEMENT DISORDERS READ MORE
NEW: DIGITAL PRESCRIPTION FOR PAIN & MOVEMENT DISORDERS
NeuroSphere Virtual Clinic connects people remotely with their doctors to prescribe and adjust treatment.
SUSTAINABILITY REPORT: DELIVERING LONG-TERM IMPACT READ MORE
SUSTAINABILITY REPORT: DELIVERING LONG-TERM IMPACT
Abbott stepped up to meet the world's 2020 needs while building a stronger, more resilient company for tomorrow.

 

 

YOUR COVID-19 TESTING QUESTIONS ANSWERED

Find answers to frequently asked questions about Abbott's COVID-19 tests.

FAQ

OUR MISSION
ILLNESS CAN STEAL LIFE'S PRECIOUS MOMENTS READ MORE
ILLNESS CAN STEAL LIFE'S PRECIOUS MOMENTS
Our life-changing technology helps get them back.
A SUSTAINABLE FUTURE  STARTS WITH HEALTH READ MORE
A SUSTAINABLE FUTURE STARTS WITH HEALTH
We're designing access and affordability into our products to reach one in three people every year by 2030.
OUR BEST INNOVATIONS, YOUR BEST SELF READ MORE
OUR BEST INNOVATIONS, YOUR BEST SELF
In everything we do, we're dedicated to helping people live more fully.
CONNECT WITH US

 

The BinaxNOW™ COVID-19 Antigen Self Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 from individuals with or without symptoms or other epidemiological reasons to suspect COVID-19 infection when tested twice over three days with at least 36 hours between tests. This test is authorized for non-prescription home use with self-collected direct anterior nasal (nares) swab samples from individuals aged 15 years or older or adult collected anterior nasal swab samples from individuals aged two years or older.

 

The BinaxNOW COVID-19 Ag 2 Card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct anterior nasal (nares) swab samples from COVID-19 symptomatic individuals tested twice over three days with at least 36 hours between tests within the first seven days of symptom onset.

  

This test is authorized for use with direct anterior nasal (nares) swab samples from individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested twice over three days with at least 36 hours between tests. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high, or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.

The BinaxNOW COVID-19 Ag Card 2 Home Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct anterior nasal (nares) swabs from individuals with or without symptoms or other epidemiological reasons to suspect COVID-19 infection when tested twice over three days with at least 36 hours between tests. This test is authorized for non-prescription home use with self-collected observed direct anterior nasal (nares) swab samples from individuals aged 15 years or older or adult collected anterior nasal swab samples from individuals aged two years or older. The BinaxNOW COVID-19 Ag Card 2 Home Test is to be performed only with the supervision of a telehealth proctor.

The BinaxNOW COVID-19 Ag tests have not been FDA cleared or approved. They have been authorized by the FDA under an emergency use authorization. The tests have been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens, and are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

The ID NOW COVID-19 EUA has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization for use by authorized laboratories and patient care settings. The test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Sign up to receive updates on Abbott's Life-Changing Technology

Enter your email address to receive Abbott Edge. See the most recent editions of our newsletter.

Please enter your email
Please complete the capctha

Intended for U.S. residents only. Please review our privacy policy and terms & conditions.

Your request failed. Please try again!
true
accessibility

You are about to exit for another Abbott country or region specific website

Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.


The website you have requested also may not be optimized for your specific screen size.

Do you wish to continue and exit this website?

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website??